Primary sclerosing cholangitis (PSC)
Board exam relevance: in 6 of more than 100 exam reports · rank 59- Synonyms
- PSC, sclerosing cholangitis, small-duct PSC, bile duct scarring
- Specialty
- Internal medicine · Liver & biliary tract
- Images
- Ultrasound 1 · X-ray 1 · MRI 1 · Histology 1
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (4)
Ultrasound
X-ray
MRI
HistologyDefinition
PSC is a chronic, progressive cholestatic liver disease. Inflammation and fibrosis lead to strictures and dilatations of the intrahepatic and/or extrahepatic bile ducts. The diagnosis is based on typical bile duct changes on cholangiography after exclusion of other causes of secondary cholangitis.
Classification
- Classic PSC: involvement of large and small bile ducts, frequently with inflammatory bowel disease
- Small-duct PSC: about 5% of patients; only small bile ducts affected, normal cholangiogram, diagnosis by histology only; progression to the classic form is possible
- PSC with features of autoimmune hepatitis (overlap form)
Occurrence & epidemiology
Prevalence is about 10 per 100,000. More than 60% of patients are men; the disease usually manifests between the ages of 30 and 40 but also occurs in children and older people. PSC is found in 2.4–7.5% of patients with ulcerative colitis and in 1.2–3.4% of patients with Crohn's disease.
Aetiopathogenesis
The cause is unknown. Immune-mediated mechanisms are suggested by the close association with inflammatory bowel disease (in 60–80% of PSC patients in Northern Europe and North America) and the frequent detection of autoantibodies such as ANA and atypical pANCA. There is also a genetic component: first-degree relatives have a markedly increased risk of disease.
The accompanying bowel disease often shows a distinct pattern: pancolitis, rectal sparing and backwash ileitis are more common than in ulcerative colitis without PSC.
Clinical features
Up to 50% of patients are symptom-free at diagnosis and are noticed only because of raised liver values. Typical complaints are right upper quadrant pain, pruritus, jaundice, fatigue and exhaustion; episodes of fever point to bacterial cholangitis. On examination, hepatomegaly and splenomegaly are the main findings.
Complications over time:
- bacterial cholangitis (in about 40%) and gallstones or choledocholithiasis (in about 50%)
- dominant strictures of the large bile ducts
- cholangiocarcinoma in 10–20% of patients, and an increased risk of gallbladder carcinoma
- increased risk of colorectal carcinoma with coexisting inflammatory bowel disease
- biliary cirrhosis with portal hypertension
Diagnosis
- Laboratory tests: alkaline phosphatase and GGT usually raised; a normal ALP (in up to 20%) does not exclude PSC, and values often fluctuate. Aminotransferases usually only 2 to 3 times raised, bilirubin usually normal at first.
- Autoantibodies: ANA and pANCA frequently positive but not diagnostic; AMA negative
- IgG4 once at diagnosis to distinguish IgG4-associated cholangitis; however, raised IgG4 levels (above 1.4 g/L) also occur in 10–15% of PSC patients
- MRCP as the most important method of cholangiography: beaded pattern of strictures and upstream dilatations of the bile ducts
- Liver biopsy only if small-duct PSC or overlap with autoimmune hepatitis is suspected; concentric, onion-skin fibrosis around bile ducts is typical
- In known inflammatory bowel disease, persistently raised cholestatic enzymes suggest PSC; however, the bowel disease may also be diagnosed only after the PSC
Treatment principles
- No drug therapy has been shown to improve prognosis; treatment targets symptoms such as pruritus and consequences of cholestasis, such as fat-soluble vitamin deficiency.
- Relevant biliary strictures are dilated endoscopically after malignancy has been excluded.
- Regular surveillance for cholangiocarcinoma, and for colorectal cancer in associated inflammatory bowel disease, is important; in advanced disease, liver transplantation is the only curative option.
Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.
Keep learning in the app
Further reading (open access)
Cross-references
More topics: Liver & biliary tract
- Liver cirrhosis
- Primary biliary cholangitis (PBC)
- Autoimmune hepatitis
- Esophageal varices and portal hypertension
- Spontaneous bacterial peritonitis (SBP)
- Steatotic liver disease (fatty liver, MASLD)
- Acute liver failure
- Alcoholic hepatitis
- Ascites
- Benign liver tumors (hemangioma, FNH, adenoma)
- Budd-Chiari syndrome
- Hemochromatosis
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.
Related pages: Liver cirrhosis · Primary biliary cholangitis (PBC) · Autoimmune hepatitis
Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.